Because overexpression of EGFR is detected in a large percentage of malignancies, targeting EGFR and its downstream signaling cascades is considered a sensible and beneficial approach in cancer therapy.23 When cells are growing and developing, the BRAF gene is frequently implicated. The gene discussed is BRAF; the disease is cancer.